Hansen makes Peter Mariani CFO
This article was originally published in Clinica
Robotic surgery specialist Hansen Medical has appointed a new chief financial officer, former Guidant chief accounting officer Peter Mariani. Mr Mariani spent nearly 12 years with heart device developer Guidant, which was acquired by Boston Scientific in April 2006 for $25.6bn. After the takeover, he co-led the initial integration of the two companies, before leaving to work as CFO of Harlan Laboratories and BMW Constructors. Mr Mariani's appointment comes after a long search by Hansen to find a new CFO. He replaces Peter Osborne, who has served as interim CFO since February 2010, following the resignation of Steve Van Dick, who held the position for four years (www.clinica.co.uk, 25 February 2010). The Mountain View, California company is currently awaiting US FDA 510(k) clearance of its Vascular Robotic System, which it hopes will boost the uptake of its robotic technology. It filed for clearance in April (www.clinica.co.uk, 12 April 2011).
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.